Cardiotoxicity associated with immune checkpoint inhibitor therapy: a meta‐analysis

Aims This study aimed to estimate the incidence of cardiac immune‐related adverse events (irAEs) in patients treated with immune checkpoint inhibitors (ICIs). Methods and results First, we performed an ICI pharmacovigilance analysis, finding 4.2% of cardiac disorders, including myocarditis, for anti...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of heart failure 2021-10, Vol.23 (10), p.1739-1747
Hauptverfasser:	Rubio‐Infante, Nestor, Ramírez‐Flores, Yoel A., Castillo, Elena C., Lozano, Omar, García‐Rivas, Gerardo, Torre‐Amione, Guillermo
Format:	Artikel
Sprache:	eng
Schlagworte:	Adverse events Cardiotoxicity Cardiotoxicity - epidemiology Cardiotoxicity - etiology CTLA‐4 Databases, Factual Heart Failure - drug therapy Humans Immune checkpoint inhibitors Immune Checkpoint Inhibitors - adverse effects Myocarditis Neoplasms - complications Neoplasms - drug therapy PD‐1 Pharmacovigilance
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!